KFDunn Merges with Aloysius Butler & Clark to Form New Division: KFDunn Life Sciences Marketing Communications
Wilmington, Delaware, May 31, 2007—Aloysius Butler & Clark (AB&C), a national healthcare marketing leader, and KFDunn, one of the country’s foremost diagnostics, devices and biotechnology marketing communications firms, have merged to form KFDunn Life Sciences, a division of AB&C. Kathleen F. Dunn will serve as the president of the new division. The merger creates one of the few life sciences marketing communications agencies in the country and makes AB&C among the first agencies to integrate life science, patient care and social marketing.
Over the past 18 years KFDunn has become a prominent agency in the life science industry by providing a full range of communication services for clinical diagnostics, radiology, molecular diagnostics, biotechnology, bioinformatics, genomics, proteomics, drug discovery and biomedical products.
Several regional businesses are represented on the client roster of KFDunn Life Sciences including Newark based Strategic Diagnostics, Inc., a major developer and producer of antibodies and immunoreagents for a broad range of applications; Immunicon Corporation, located in the Huntington Valley, which develops and commercializes diagnostic and research products for rare cell analysis and molecular research, with an initial focus on cancer; and B. Braun, located in Bethlehem, which supplies the global healthcare market with products for anesthesia, intensive medicine, cardiology, extracorporeal blood treatment and surgery, as well as services for hospitals, general practitioners and the homecare sector.
KFDunn agency founder and president Kathleen F. Dunn said the merging of the two firms strengthened the capabilities of both. “Having merged with an agency with a talented staff of more than 55, we can offer more marketing services, including public relations, media planning and placement, and in-house web design and production,” said Dunn. “It also gives our life sciences clients a window into the world of patient care.”
The agency’s social marketing expertise was expanded in late 2006 with the addition of Shari Short, who most recently served as a partnership program coordinator for the National Cancer Institute (NCI). Short’s experience with research and program development and evaluation has equipped the agency to provide evidence-based healthcare marketing to reach patient populations and influence attitudes and behaviors.
AB&C president and CEO John Hawkins said the merger and the addition of social marketing is more than an expansion of AB&C’s healthcare marketing capabilities. “For 25 years we have served hospitals, health systems, insurers and other healthcare organizations that focus primarily on healthcare delivery,” said Hawkins. “As scientific advancements drive a more personalized and preemptive approach to medicine and society places a growing emphasis on health literacy and compliance, life sciences and social marketing become more important. By adding expertise in these areas and integrating our approaches, we can serve clients better and help them with the dramatic changes ahead.”
AB&C (www.a-b-c.com) is a 40-year-old full-service marketing communications agency with offices in Wilmington, Delaware, and Philadelphia, Pennsylvania. Established in business-to-business and consumer marketing, the agency brings a fresh perspective to local, regional, national and international accounts in a variety of industries.